Laura G. Eichorn

52 year

Health Technology

Consumer Services

Profile

Laura G.
Eichorn is the founder and currently serves as the Chief Financial Officer at Imago BioSciences, Inc., a company she founded in 2012.
She previously worked as the Vice President-Operations & Finance at FerroKin BioSciences, Inc. Ms. Eichorn obtained her undergraduate degree from Frostburg State University.

Laura G. Eichorn active positions

Companies	Position	Start
IMAGO BIOSCIENCES, INC.	Founder	2012-02-29

All active positions of Laura G. Eichorn

Former positions of Laura G. Eichorn

Companies	Position	End
FerroKin BioSciences, Inc. FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA.	Director of Finance/CFO	-

See the detail of Laura G. Eichorn's experience

Training of Laura G. Eichorn

Frostburg State University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Laura G. Eichorn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
FerroKin BioSciences, Inc. FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA.	Health Technology
Imago BioSciences, Inc. Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA.	Health Technology